CannTrust Is Listed On The TSX | CannTrust (TRST:TSX)

© 2020 All Rights Reserved.

BTV new listing alert! CannTrust is listed on the TSX under the symbol TRST. CannTrust is a vertically integrated, international licensed producer of medical cannabis soon to be recreational cannabis. We’ve just signed a deal with Stenocare in Denmark and that’s basically a beachhead for Europe. We’re using that as a launch point, they’re one of the only licensed producers in Denmark. They’ve got 75% coverage in all the pharmacies which is where it’s going to be distributed over in Denmark. What sets CannTrust apart from our peers is above all standardization. Every single product that CannTrust puts out has a label claim on it be it our dried product and our oil product and all the future products will be standardised as well and that plays very well into the recreational market.

About CannTrust

CannTrust is a federally regulated licensed producer, who brings more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry. We apply this expertise to produce 100% pesticide free standardized Medical Cannabis for patients in need. At CannTrust™ we are committed to research and innovation. As well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive pharma partner Apotex are diligently innovating and developing products. CannTrust has been granted a Section 9 License by Health Canada under the Narcotic Control Regulations. This allows us to expand our product development and research to include pharmaceuticals in an effort to make it easier for patients to use Medical Cannabis today and in the future. Our onsite laboratory with advanced technology and equipment for testing and research on the medical use of cannabis provides CannTrust with the ability to develop and rigorously test our products at any point. We continue to evolve our patient and medical practitioner education program about Medical Cannabis, as a result of an industry leading compassionate use program to support patients with financial needs. For more information on CannTrust (TRST:TSX) please fill out the form below.

Request Investor Info